ArticlePDF AvailableLiterature Review

Reversible cerebral vasoconstriction syndrome

Authors:

Abstract and Figures

Reversible cerebral vasoconstriction syndrome is characterised by severe headaches with or without seizures and focal neurological deficits, and constriction of cerebral arteries which resolves spontaneously in 1-3 months. It affects females slightly more than males, and mean age of onset is around 45 years. Approximately 60% of cases are secondary, mainly postpartum and after exposure to vasoactive substances. The major complications are localised cortical subarachnoid haemorrhage (22%) and parenchymal ischaemic or haemorrhagic strokes (7%) which may leave permanent sequelae. Diagnosis requires the demonstration of the "string of beads" appearance of cerebral arteries on angiography, with complete or almost complete resolution on repeat angiography 12 weeks after onset. Nimodipine seems to reduce thunderclap headaches within 48 h but has no definite effect on the haemorrhagic and ischaemic complications.
Content may be subject to copyright.
REVIEW Pract Neurol 2009; 9: 256–267
Reversible cerebral
vasoconstriction syndrome
Anne Ducros,
1
Marie-Germaine Bousser
2
1
Consultant Neurologist,
Emergency Headache Centre,
Assistance Publique des Hoˆpitaux
de Paris, Lariboisie`re Hospital, Head
and Neck Centre, Paris, France
2
Professor of Neurology, Neurology
Department, Assistance Publique
des Hoˆpitaux de Paris, Lariboisie`re
Hospital, Head and Neck Centre,
Paris, France
Correspondence to:
Dr Anne Ducros
Consultant Neurologist, Urgences
Ce´phale´es, Hoˆpital Lariboisie`re,
2 rue Ambroise Pare´,
75475 Paris Cedex 10, France;
anne.ducros@lrb.aphp.fr
Reversible cerebral vasoconstriction syndrome is characterised by severe
headaches with or without seizures and focal neurological deficits, and
constriction of cerebral arteries which resolves spontaneously in 1–3 months.
It affects females slightly more than males, and mean age of onset is around
45 years. Approximately 60% of cases are secondary, mainly postpartum and
after exposure to vasoactive substances. The major complications are localised
cortical subarachnoid haemorrhage (22%) and parenchymal ischaemic or
haemorrhagic strokes (7%) which may leave permanent sequelae. Diagnosis
requires the demonstration of the ‘‘string of beads’’ appearance of cerebral
arteries on angiography, with complete or almost complete resolution on
repeat angiography 12 weeks after onset. Nimodipine seems to reduce
thunderclap headaches within 48 h but has no definite effect on the
haemorrhagic and ischaemic complications.
Reversible cerebral vasoconstriction
syndrome is characterised by the
association of severe headaches with
or without additional neurological
symptoms, and constriction of cerebral arteries
which resolves spontaneously in 1–3
months.
1, 2
The most common clinical feature
is a severe acute headache, often thunderclap
in nature—a sudden excruciating headache that
peaks in less than 1 min, like a ‘‘clap of
thunder’’—mimicking that of a ruptured aneur-
ysm. The major complications are localised
cortical subarachnoid haemorrhages (20–25%)
and ischaemic or haemorrhagic strokes
(5–10%).
3–6
In contrast with the arterial
abnormalities that are reversible within a few
weeks, these strokes may leave permanent
sequelae and can even be fatal.
2, 7–9
Reversible cerebral vasoconstriction syn-
drome was the name proposed in 2007 by
Calabrese et al to group all the rather similar
cases reported over the years under many
different appellations (table 1).
2, 3, 10, 11
These
illustrate the fact that the diagnosis may be
challenging. On the one hand, severe forms
have been considered to be mild forms of
cerebral angiitis because of the similar angio-
graphic features,
12, 13
while on the other hand,
purely cephalalgic forms have been considered
as varieties of primary headache syndromes (ie,
headaches spontaneously produced by the
activation of cerebral/cranial pain circuits
without an underlying lesion
10, 14
).
However, during the past 5–10 years, it has
been increasingly recognised as a distinct
syndrome due to a transient and reversible
disturbance of arterial tone regulation, with-
out inflammation of the arteries, mainly
characterised by severe headaches, which
are secondary and symptomatic of the
underlying vascular abnormality.
AN UNDERDIAGNOSED
CONDITION
Reversible cerebral vasoconstriction syn-
drome has been reported in patients aged
256 Practical Neurology
10.1136/jnnp.2009.187856
13–70 years.
3, 15
Mean age of onset is around
45 years with a female to male preponder-
ance from between about 2 and 10:1.
3, 13, 14
The exact incidence is unknown. This syn-
drome, although rare, is probably still under-
diagnosed, particularly the pure cephalalgic
form. Only three series including more than
10 patients have been published.
NA retrospective American series of 16
patients hospitalised for suspected CNS
angiitis, of whom 10 had repeat angio-
graphy to assess reversibility of vasocon-
striction.
13
NA prospective Taiwanese series of 56
patients with recurrent thunderclap
headaches of whom 22 had proven initial
vasoconstriction, then a series of 32
patients (including 12 from the first
series) with the proven syndrome.
6, 14
NOur prospective French series of 67 cases,
seen in a single institution between 2004
and 2007, who all had vasoconstriction
and repeat angiography showing its
resolution.
3
MECHANISMS AND CAUSES
Although the pathophysiology remains
unknown, the prevailing hypothesis is of a
transient disturbance in the control of
cerebral vascular tone leading to segmental
and multifocal arterial constriction and
dilatation.
2
This disturbance may be spontan-
eous (so-called idiopathic reversible cerebral
vasoconstriction syndrome), while 25–60% of
cases are secondary, mostly to exposure to
vasoactive sympathomimetic or serotoniner-
gic substances, and/or to the postpartum
state (table 2).
2, 3, 9, 13, 16
Vasoactive substances
The incriminated substances include various
medications such as selective serotonin
reuptake inhibitors and all a-sympathomim-
etics, often used as over the counter nasal
decongestants, some diet pills and herbal
medications, and most illicit drugs, including
cannabis (which is the most frequent cause in
France).
2, 3, 7, 8, 16, 17
In some patients, the
syndrome occurs after just a few days of
exposure while in others it occurs after
several months of either regular or irregular
exposure to one or several of these sub-
stances, at normal or excessive doses. Acute
alcoholic intoxication may be an additional
precipitating factor but has only been
incriminated in association with exposure to
other drugs, such as cannabis and/or ecstasy/
and or cocaine.
3
Postpartum
Postpartum reversible cerebral vasoconstric-
tion syndrome starts in two-thirds of cases
TABLE 1 Various appellations of the reversible cerebral vasoconstriction
syndrome
lIsolated benign cerebral vasculitis or angiopathy
lCall–Fleming syndrome
lCNS pseudovasculitis
lBenign angiopathy of the central nervous system
lPostpartum angiopathy
lMigrainous vasospasm
lMigraine angiitis
lIdiopathic thunderclap headache with reversible vasospam
lDrug induced cerebral vasculopathy
lFatal vasospasm in migrainous infarction
TABLE 2 Causes of reversible cerebral vasoconstriction syndrome and
associated conditions
Postpartum
lWith or without exposure to vasoactive substances, eclampsia/pre-
eclampsia
Exposure to vasoactive substances
lCannabis, cocaine, ecstasy, amphetamines, LSD, binge drinking
lSelective serotonin reuptake inhibitors
lNasal decongestants—phenylpropanolamine, pseudoephedrine, ephedrine
lErgotamine tartrate
lMethergine
lBromocriptine, lisuride
lTriptans
lIsometheptine
lNicotine patches
lGinseng
Catecholamine secreting tumours
lPhaeochromocytoma, bronchial carcinoid tumour, glomus tumours
Exposure to immunosuppressants or blood products
lTacrolimus (FK-506), cyclophosphamide, erythropoietin, intravenous
immunoglobulin, red blood cell transfusion, interferon a
Miscellaneous
lHypercalcaemia, porphyria, head trauma, subdural spinal haematoma,
carotid endarterectomy, neurosurgical procedures, CSF hypotension
Extra or intracranial large artery disorders
lCervical dissection, unruptured intracranial aneurysm, dysplasia
257Ducros, Bousser
www.practical-neurology.com
during the first week after delivery, usually
after a normal pregnancy.
8, 9, 16
In 50–70% of
cases, it is associated with the intake of
vasoconstrictors, mostly ergots used to treat
postpartum haemorrhage or to inhibit lacta-
tion (eg bromocriptine, methergine).
9
Other causes
Many other causes have been reported, such
as catecholamine secreting tumours, head
trauma, neurosurgical procedures, carotid
endarterectomy and intracranial hypoten-
sion.
2, 8, 16, 18
The syndrome may also be
associated with other extra or intracranial
arterial lesions such as cervical artery dissec-
tion, especially postpartum, unruptured intra-
cranial aneurysm, and arterial dysplasia.
3, 16, 19
The mechanism of the link between these
arterial abnormalities and the vasospastic
process is unknown.
It is important to emphasise that the
headaches are secondary headaches, sympto-
matic of the vascular disorder; they have
nothing to do with migraine which is a
primary headache without any underlying
causal lesion.
1
A history of migraine is found
in only 16–20% of reversible cerebral vaso-
constriction syndrome cases, no different
from the prevalence of migraine in the
general population.
3, 14
Overlap with the posterior
reversible encephalopathy
syndrome
The reversible cerebral vasoconstriction syn-
drome may complicate severe conditions such
as intravenous immunoglobulin therapy in
Guillain–Barre´ syndrome, immunosuppression
for transplantation or septic shock. In these
complex cases it is almost always associated
with a neurotoxic state called the ‘‘posterior
reversible encephalopathy syndrome’’ or
PRES. This clinicoradiological syndrome has
similar clinical features to severe reversible
cerebral vasoconstriction syndrome (acute
headache, confusion, seizures, cortical blind-
ness) but a characteristic MR imaging pattern,
better visualised on FLAIR than on T2
sequences.
20
There is bilateral symmetrical
hemispheric junctional/boundary zone high
signal affecting the cortex, and subcortical
and deep white matter to varying degrees.
Lesions affect mainly parietal/occipital
regions (98%) but also the superior frontal
sulcus, temporal–occipital junction and may
also be seen in the cerebellum, basal ganglia,
brainstem and deep white matter.
21, 22
This
vasogenic oedema is usually totally reversible
in a few days. However, infarction or tissue
injury with cytotoxic oedema (leading to focal
areas of restricted MR diffusion) may occur
in areas of severe hypoperfusion.
21, 23
Haemorrhage (focal haematoma or subarach-
noid blood) is seen in about 15% of cases.
21
The posterior reversible encephalopathy
syndrome was initially described in associa-
tion with eclampsia or during ciclosporin
treatment after transplantation, always in the
setting of severe hypertension. But it is now
recognised as a complication of many other
conditions, including pre-eclampsia/eclamp-
sia, immunosuppression after allogenic bone
marrow or organ transplantation, autoim-
mune disease, high dose chemotherapy and
septic shock.
21, 24
Like the reversible cerebral vasoconstriction
syndrome, the exact pathophysiology of the
posterior reversible encephalopathy syndrome
is unknown, and two hypotheses are debated.
25
The most popular is that severe arterial
hypertension leads to a failure of cerebral
autoregulation with subsequent hyperperfu-
sion and vasogenic oedema. In the emerging
second hypothesis, T cell and/or endothelial cell
activation may trigger cerebral vasoconstriction
leading to hypoperfusion with subsequent
brain ischaemia and vasogenic oedema.
Whatever the pathophysiology, numerous
recent studies have shown that:
Nreversible cerebral vasoconstriction is a
frequent if not a constant feature of the
posterior reversible encephalopathy syn-
drome
N20–30% of cases are normotensive
Nnormotensive cases have vasogenic
oedema that is more extensive than
hypertensive cases which suggests that
hypertension may sometimes be a reac-
tion to the increase in cerebral blood flow
in some cases.
21, 23–26
Besides the association of reversible cere-
bral vasoconstriction syndrome and the
posterior reversible encephalopathy syndrome
in the setting of severe conditions, it is
important to appreciate that about 10% of
the former cases are associated with the
The headaches are
secondary
headaches,
symptomatic of the
vascular disorder;
they have nothing
to do with migraine
258 Practical Neurology
10.1136/jnnp.2009.187856
posterior reversible encephalopathy syn-
drome, regardless of the cause: idiopathic,
secondary to a vasoactive substance or to the
postpartum state, or associated with arterial
dissection.
3, 16
SYMPTOMS AND SIGNS
Headache
Headache is often the only symptom, as in
75% of our French series.
3
It is severe in most
patients and is often of the thunderclap
type—very sudden, peaking in less than 1 min
and very intense.
3, 6, 13, 14
Multiple thunderclap
headaches recurring every day or so over 1–
4 weeks are almost pathognomonic.
2, 3, 6, 14
The headache is typically bilateral, with a
posterior onset rather than diffuse, of severe
to very severe intensity, sometimes excruciat-
ing, with agitation, shouting and yelling,
often associated with nausea, vomiting,
photophobia and phonophobia. Migraineurs
clearly identify the thunderclap headaches as
different from their usual headaches. Severe
pain usually lasts 1–3 h (but ranges from a
few minutes to several days) and 50–75% of
patients describe a permanent mild back-
ground headache between thunderclap
attacks. About 80% of patients report at
least one trigger factor: sexual activity,
straining, emotion, physical effort, coughing,
sneezing, urinating without effort, bathing or
showering and sudden head move-
ment.
2, 3, 6, 14
In some patients, all their
thunderclap headaches are triggered by one
or several of these factors while in others
some thunderclap headaches occur at rest,
and some after a trigger. In our experience
in an emergency headache centre, patients
presenting with recurrent sexual thunderclap
headaches over a few days almost always
have reversible cerebral vasoconstriction
syndrome.
Some patients have a single thunderclap
headache. Some patients describe acute
headache attacks awaking them from
sleep, a situation that does not allow
them to be sure of the thunderclap onset.
Rarely, the headache is more progressive
and moderate. In the presence of lateral or
posterior neck pain, it is important to
carefully look for carotid or vertebral
artery dissection.
3, 19
Focal deficits and seizures
The frequency of other neurological signs and
symptoms depends on how the patients are
recruited into the studies and varies from 9%
to 63%, and for seizures from 0% to
21%.
3, 6, 13, 14
Indeed, it is the presence of
such features that usually leads to extensive
investigations which, by contrast, are fre-
quently not performed when the patient has
isolated headaches (even though for a
thunderclap headache a normal CT scan
should be followed by a lumbar puncture to
look for blood in the CSF followed often by
imaging of the cervical and cerebral arteries
and the intracranial veins).
Deficits and seizures are of many types.
Some transient focal deficits have a sudden
onset like transient ischaemic attacks, while
others begin progressively and successively
over a few minutes, with positive visual and/
or sensory symptoms mimicking migrainous
auras. Persistent focal deficits are usually due
to a haematoma or infarction. Impairment of
consciousness is infrequent and usually mild,
but coma may occur in rare severe cases with
multiple strokes.
General examination
The general physical examination is usually
normal, except in complex conditions asso-
ciated with the syndrome and the posterior
reversible encephalopathy syndrome in the
setting of eclampsia, septic shock, immuno-
suppression, etc. About 25–30% of patients
have blood pressure surges during the
thunderclap headaches and some patients
also have a facial flush.
INVESTIGATIONS
Brain CT and MRI
Non-contrast CT brain scan is usually normal
while the more sensitive MRI was abnormal in
about one-third of patients in the prospective
series.
2, 3, 14
In our patients with purely the
cephalalgic reversible cerebral vasoconstric-
tion syndrome, MRI showed a cortical sub-
arachnoid haemorrhage (SAH) in 20% and the
appearance of posterior reversible encephalo-
pathy in 10%; and in patients that presented
with a persistent focal deficit, MRI showed an
infarct or haematoma in 100%. In our 67
patients, the most frequent abnormality was
a small localised cortical SAH (22%), unilateral
259Ducros, Bousser
www.practical-neurology.com
or bilateral, visible as high signal on FLAIR
in some sulci near the convexity
(fig 1).
3, 4, 13, 16, 27–29
Focal intracerebral hae-
morrhage occurred in 6% of our 67 cases.
3
This may be single or multiple, cortical or deep
and of variable volume (fig 2).
3, 5, 30
Subdural
haemorrhage has also been reported.
30
There
may be more than one type of haemorrhage
in any one patient. Infarction is rare; 4% in
our series.
3
The infarcts may be single or
multiple and often have a boundary zone
distribution (fig 3).
2
In 10% of patients,
symmetrical high signal on FLAIR is consistent
with the posterior reversible encephalopathy
syndrome (fig 4).
3
Finally, cervical FAT/SAT
sequences are very useful to search for any
associated cervical artery dissection.
Cerebral angiography
Angiography shows segmental narrowing and
dilatation (string of beads) of one or more
cerebral arteries (fig 5).
2, 31
Non-invasive angio-
graphy (MRA or CTA) was only 80% sensitive in
our series compared with the gold standard of
catheter angiography which is by definition
100% sensitive (because it defines the syn-
drome), although nowadays rarely necessary
(fig 6).
3
If another condition or another lesion is
very unlikely, and if the initial MRA/CTA is
definitely normal, and if there is no cortical SAH
and no stroke on MRI, we do not perform a
catheter angiogram. But depending on the
clinical state of the patient, we may repeat
transcranial Doppler ultrasound (see below)
with or without repeat MRA/CTA, or we simply
follow-up. Of course, in these patients,
no definite diagnosis is possible. The first
angiogram, whatever its type, may be normal
if performed very early, within 4–5 days of
onset of symptoms; therefore, if the first MRA
or CTA is normal, a second angiogram a few
days later may be diagnostic.
3
Calibre irregularities may affect the anterior
as well as the posterior cerebral circulation,
and are mostly bilateral and diffuse; large
arteries such as the basilar or the carotid
siphon may also be involved.
10
The narrowings
are not fixed, and a repeat angiogram after a
few days may show the resolution of some
with new zones of constriction often involving
more proximal vessels.
The syndrome may be associated with single
or multiple unruptured cerebral aneurysms
(6% in our French series which is not that
much more frequent than in the general
middle aged population, but these patients
had no red blood cells in the CSF and no
extravasation of contrast on catheter angio-
graphy), arterial dysplasia, and vertebral or
carotid dissection.
3, 16
The association with
dissection seems more frequent in females,
particularly postpartum.
3, 19
Ultrasound
Cervical ultrasound examination is usually
normal except in cases associated with
arterial dissection. Transcranial Doppler on
the other hand is very useful for monitoring
the temporal evolution of cerebral vasocon-
striction. In the prospective Taiwanese study
of 32 patients, the maximal mean flow
velocity in the middle cerebral artery exceeded
80 cm/s in 81% of patients and 120 cm/s in
47%, but never exceeded 200 cm/s.
6
Sequential studies are more sensitive than a
single investigation because velocities may be
normal during the first few days, then begin
to increase and reach a peak at the end of the
third week after headache onset.
3, 6
Transcranial Doppler is also useful to monitor
the vasospam but may not be sufficient to
reliably assess reversibility which still requires
a repeat angiogram. Moreover, some patients
still have raised velocities at the end of the
third month, even when their MRA has
returned to normal.
6
Cerebrospinal fluid
There are mild abnormalities in more than
half of the patients with an excess of white
Figure 1
Cortical subarachnoid haemorrhage in
reversible cerebral vasoconstriction
syndrome. (A) CT brain scan showing a
small right frontal haemorrhage. (B) In
another patient with a normal CT scan,
MRI (FLAIR) shows bilateral cortical
subarachnoid haemorrhage with high
signal in several sulci.
260 Practical Neurology
10.1136/jnnp.2009.187856
blood cells (5–35/mm
3
) and red blood cells
(with or without visible subarachnoid blood
on MRI) and increased protein levels up to
1 g/l.
2, 3
If the lymphocytic reaction exceeds
10 cells/mm
3
, it is better to repeat the lumbar
puncture after a few weeks to make sure it is
normal and exclude chronic meningitis.
Other investigations
Blood tests are usually normal but may show
a moderate and transient inflammatory
response, notably in patients with orophar-
yngeal infections who took nasal deconge-
stants. Urine toxicology can be useful
(cannabis, cocaine, amphetamines, ecstasy).
If there are blood pressure surges during the
headache phase, urinary amines have to be
tested for pheochromocytoma.
TEMPORAL
CLINICORADIOLOGICAL COURSE
One of the main characteristics of reversible
cerebral vasoconstriction syndrome is the
temporal pattern of the clinical features and
the associated arterial abnormalities (table 3).
3
The first symptom is usually a thunderclap
headache that recurs during the first week,
with the last attack at a mean of 7–8 days
after onset. Mild background headache may
then persist in about 75% of patients, and
finally all significant headaches have gone by
about 3 weeks.
3, 6
Any intracranial haemor-
rhage and posterior reversible encephal-
opathy are early complications during the
first week while ischaemic complications
(transient ischaemic attacks and infarction)
occur later, at the end of the second week,
sometimes when the headaches have
improved or even resolved.
3, 6, 14
Moreover, as already stressed, vasocon-
striction may not be disclosed by early
angiography but found only later on repeat
investigation. Maximal intracranial flow velo-
cities are reached at a mean of 22 days after
onset; these velocities are thus maximal when
the headache has disappeared.
6
The temporal
course of the clinical and radiological features
suggests a dynamic process starting in distal
arteries not visualised on angiography, which
progresses towards moderate to large calibre
arteries.
DIAGNOSIS
The diagnosis should be suspected in all
patients with thunderclap headache, with or
without other neurological symptoms, after
the exclusion of all other causes (table 4).
1, 32
With the current diagnostic criteria, it is
impossible to make the diagnosis in the
Figure 2
CT showing intracerebral haemorrhage
in the reversible cerebral
vasoconstriction syndrome which may
be single (A, C, D) or multiple (B), lobar
(A, B, D) or deep (C), isolated or
associated with cortical subarachnoid
haemorrhage (B, right frontal cortical
subarachnoid haemorrhage, arrows) or
with an acute subdural haemorrhage
(D, occipital subdural blood, arrow).
Figure 3
Infarction in reversible cerebral
vasoconstriction syndrome: MRI (FLAIR)
3 months after the acute phase
showing the sequelae of bilateral
occipital and left temporoparietal
infarcts.
261Ducros, Bousser
www.practical-neurology.com
absence of headache. However, reversible
cerebral vasoconstriction syndrome without
headache or with very minimal headache
does probably exist. We had a young women
with multiple infarcts and minimal headache,
smoking cannabis, with a characteristic MRA
and transcranial Doppler which were both
normal again at 2 months, and no other
cause to better explain her illness.
As already stressed, recurrent thunderclap
headaches over a few days immediately
suggests the syndrome as does non-aneur-
ysmal subarachnoid haemorrhage and/or
cryptogenic stroke, notably when the patient
has severe headache as well.
3, 28
Appropriate
investigations, including transcranial Doppler,
CTA, MRA or eventually catheter angiography
should be performed to demonstrate the typical
angiographic pattern. The definitive diagnosis
can however only be confirmed when the
reversibility of the arterial abnormalities is
assessed at 12 weeks from onset although
complete resolution may be slower in some
patients.
2
Indeed, in the Taiwanese series of 32
patients, although two-thirds had complete
normalisation of their vessels on MRA at
3 months, only marked improvement was
noted in the rest.
6
DIFFERENTIAL DIAGNOSIS
Thunderclap headache revealing
subarachnoid haemorrhage
Every thunderclap headache must be con-
sidered symptomatic and requires immediate
investigation which will reveal an underlying
cause in half of the patients, mainly a
vascular disorder (table 4).
32, 33
The most
important cause is SAH. Therefore, a non-
contrast CT scan, followed by CSF analysis for
blood products if the scan is normal, is
mandatory in all patients. Aneurysmal rupture
is the most frequent cause of SAH (85%)
while other less frequent causes include
reversible cerebral vasoconstriction syndrome
itself which of course can be confusing.
3, 28
Figure 4
Posterior reversible encephalopathy
syndrome during reversible cerebral
vasoconstriction syndrome: MR FLAIR
high signal is mainly symmetrical and
may be confluent, predominating in the
occipital region (A, a postpartum case)
or patchy and moderate (C, an
idiopathic case) with resolution in both
patients on MRI at 1 month (B, D).
Diagnostic criteria for reversible cerebral vasoconstriction syndrome
(adapted from the International Headache Society diagnostic criteria
for ‘‘acute reversible cerebral angiopathy’’ and the criteria proposed
in 2007 by Calabrese
et al
1, 2
)
lAcute and severe headache (often thunderclap headache) with or without focal
neurological deficits or seizures
lMonophasic course without new symptoms more than 1 month after clinical onset
lSegmental vasoconstriction of cerebral arteries demonstrated by angiography (MRA, CTA
or catheter)
lExclusion of subarachnoid haemorrhage due to a ruptured aneurysm
lNormal or near normal CSF (protein ,1 g/l, white cells ,15/mm
3
, normal glucose)
lComplete or marked normalisation of arteries demonstrated by a repeat angiogram (MRA,
CTA or catheter) after 12 weeks, although they may be normal earlier
262 Practical Neurology
10.1136/jnnp.2009.187856
However, several features help to distinguish
one from the other.
2–4, 29
The crucial point is
that cortical SAH due to reversible cerebral
vasoconstriction syndromes does not corre-
late with the site and severity of vasospasm in
contrast with aneurysmal SAH which does
correlate with the site and severity of
vasospasm. Indeed, SAH due to reversible
cerebral vasoconstriction syndrome is typi-
cally localised, overlying the lateral or super-
ior cortical surface, with only a minimal or
moderate amount of blood, while the vaso-
constriction is widespread and multifocal,
affecting medium and large arteries remote
from the site of bleeding. Moreover, the
typical angiographic pattern of reversible
cerebral vasoconstriction syndrome includes,
in addition to the multifocal vasoconstriction,
multifocal segmental dilatations that are
easily seen and sometimes large, producing
the characteristic ‘‘string of beads’’ or
‘‘sausage-string’’ appearance. By contrast,
aneurysmal haemorrhage tends to be more
obvious near the ruptured aneurysm where it
directly triggers the vasospasm, which is thus
not multifocal but affects only one or two
medium sized arteries close to the site of
bleeding.
Other causes of thunderclap
headache
Besides SAH, thunderclap headache may be
the presenting symptom of several other
vascular and non-vascular disorders.
32, 33
NOther intracranial haemorrhages, notably
cerebellar or intraventricular, are respon-
sible for 5–10% of thunderclap head-
aches, and the diagnosis is easily made by
CT scan.
NRarely infarcts, notably cerebellar infarcts,
may present with an isolated thunderclap
headache with a normal CT scan within
the first few hours, MRI (diffusion
sequences) being much more sensitive.
Some cerebellar infarcts present with
‘‘pseudo SAH’’ without even vertigo, and
it may be difficult to examine patients for
gait ataxia who are vomiting and have a
very severe headache.
NSeveral other vascular disorders may
present with isolated thunderclap head-
ache: cervical and intracranial arterial
dissection, intracranial venous thrombo-
sis, giant cell arteritis, pituitary apoplexy
and some symptomatic but as yet
unruptured aneurysms (although bleed-
ing may be visible within the wall on
MRI). A number of these causes have a
normal CT brain scan and CSF, making it
mandatory to perform brain MRI with
cervical and cerebral angiography and
venography (table 4).
Figure 5
Catheter angiography in the reversible
cerebral vasoconstriction syndrome:
multiple segmental narrowings and
dilatations affecting medium sized
arteries (A, B) and/or large sized arteries
(B, C), from the anterior (A, C) or
vertebrobasilar circulation (B).
Figure 6
MR angiography in the reversible
cerebral vasoconstriction syndrome
performed 8 days after headache onset:
multiple narrowings (arrows) of the
right middle cerebral artery and both
posterior cerebral arteries, with
segmental dilatation of the left middle
cerebral artery (large arrow) (A).
Resolution of abnormalities at
3 months (B).
263Ducros, Bousser
www.practical-neurology.com
NFinally, an isolated thunderclap headache
may be the presentation of several non-
vascular disorders including acute sinu-
sitis, meningitis or meningoencephalitis,
acute tumoral or non-tumoral intracra-
nial hypertension, and CSF hypoten-
sion.
32, 33
The problem of primary cerebral
angiitis
The rare severe forms of reversible cerebral
vasoconstriction syndrome raise the possibi-
lity of cerebral angiitis, notably primary
angiitis of the CNS,
2, 12, 13, 34, 35
when it is
crucial to start steroids and immunosuppres-
sants as early as possible. On the other hand,
in reversible cerebral vasoconstriction syn-
drome it is important not to expose the
patient to the risks of a brain biopsy and
prolonged immunosuppression. Of course, in
the acute phase it may be impossible to
distinguish the two conditions on the basis of
angiography (see below) but there are some
distinguishing features:
NClinically, reversible cerebral vasocon-
striction syndrome has an acute onset
followed by a monophasic course usually
without any new complications after
4 weeks
3
; this can only be a retrospective
criterion.
NOnset in the postpartum phase or after
exposure to vasoactive substances is very
suggestive of reversible cerebral vasocon-
striction syndrome.
NIn primary angiitis of the CNS, the onset
is more insidious, and the headache is not
of the thunderclap type, but rather
subacute and progressive, then accom-
panied by transient deficits, and even-
tually multiple infarcts.
NMRI is often normal in reversible cerebral
vasoconstriction syndrome (70%) but is
abnormal in most cases of primary
angiitis of the CNS (90%) showing small,
multiple, deep or superficial infarcts of
different ages, with or without associated
white matter abnormalities.
NThe CSF is markedly abnormal in most
cases of primary angiitis of the CNS
(.95%) showing an inflammatory reac-
tion, while it is normal (40–80%) or
shows only mild abnormalities in rever-
sible cerebral vasoconstriction syndrome.
NCatheter angiography is frequently nor-
mal in primary angiitis of the CNS while it
is by definition always abnormal in
reversible cerebral vasoconstriction syn-
drome. Some aspects are suggestive of
angiitis and are not observed in reversible
cerebral vasoconstriction syndromes: irre-
gular and asymmetrical arterial stenoses
or multiple occlusions.
2, 34
If there is persistent uncertainty it may be
best to wait a few days; reversible cerebral
vasoconstriction syndrome should stabilise
and improve quickly with regression of the
vasoconstriction while any arterial irregula-
rities in primary angiitis of the CNS do not
improve so fast. Treatment with immunosup-
pressants should be reserved for patients with
biopsy proven vasculitis (a few patients with
reversible cerebral vasoconstriction syndrome
and persisting diagnostic uncertainty have
had to have a brain biopsy but this did not
show vasculitis).
5, 13, 36, 37
PROGNOSIS
The eventual prognosis is determined by any
stroke which occurred in 6–9% of cases in the
prospective series.
3, 6, 14
Higher percentages
have been reported in retrospective series and
literature reviews
2, 9, 13
but are probably an
overestimate because of publication bias,
recruitment of severe cases in stroke units,
and because cases with headache only might
have been overlooked. However, a few fatal
cases have been published, notably postpar-
tum.
9
During the months following the acute
phase, one-third of the patients report
TABLE 3 Mean delay from headache onset to the other features of
reversible cerebral vasoconstriction syndrome (adapted from Ducros
et
al
3
)
Delay from headache onset to
No of days
(mean (SD) [range])
Diagnosis of cerebral haematoma 1.7 (2) [0–4]
Diagnosis of subarachnoid haemorrhage 5 (5) [0–20]
First seizure 3 (1.4) [2–4]
Posterior reversible encephalopathy syndrome 4 (1.9) [1–6]
Last recurrent thunderclap headache 7.4 (5.6) [0–28]
Transient neurological deficit 11.6 (4.9) [0–23]
Symptoms of cerebral infarction 13.5 (2.1) [12–15]
Diagnosis of cerebral infarction* 12 (3) [9–15]
*Diagnosis of infarction may precede symptoms of infarction because an
asymptomatic infarct was found in one patient who had a repeat MRI at day 9.
264 Practical Neurology
10.1136/jnnp.2009.187856
persistent mild headaches often with fatigue.
Some patients develop depression. Relapses
do occur but without long term follow-up
studies the rate is unknown.
27
In our series of 67 patients followed for a
mean of 3.2 years (range 26–62 months), we
have so far not observed any angiographically
proven recurrence. However, 3 years after a
severe attack complicated by an occipital
haemorrhage, one patient had a recurrence of
multiple thunderclap headaches over 1 week,
after smoking cannabis. He did not seek
medical advice and it was thus impossible to
make a firm diagnosis. In another patient not
included in our first case series, who had a
proven syndrome, multiple sexual thunderclap
headaches recurred 6 months later, 2 days
after starting a selective serotonin reuptake
inhibitor. He did not seek medical attention
but remembered our recommendation,
stopped the antidepressant and had no more
thunderclap headaches.
TREATMENT
Symptomatic treatment includes analgesics
(sometimes even morphine), antiepileptic
drugs for any seizures, monitoring blood
pressure, hospitalisation in an intensive care
unit in severe cases, and rest for all other
patients for a few days to a few weeks
according to the severity of their headaches.
Patients having triggered thunderclap head-
aches should be advised to avoid the trigger,
such as sexual activity and any other physical
TABLE 4 Investigation of a thunderclap headache
Investigation Indications
Causes that may be detected by this
investigation
Non-contrast CT brain scan
(with visualisation of sinuses
if symptoms suggest acute
sinusitis)
All thunderclap headaches as first
investigation
Subarachnoid haemorrhage (90% within the
first 24 h), intracerebral haematoma,
intraventricular haemorrhage, subdural
haematoma (rare cause of thunderclap
headache), some infarcts particularly in the
cerebellum, hydrocephalus, tumours, acute
sinusitis
CSF All CT normal thunderclap headaches Subarachnoid haemorrhage, meningitis
ESR and C reactive protein Age .60 years Giant cell arteritis (very rare cause of
thunderclap headache)
MRI (diffusion, FLAIR,
gradient-echo, sagittal T1, T1
with gadolinium, cervical
FAT/SAT), MRA and MRV
All thunderclap headaches after
normal CT and normal or near normal
CSF.
Intracranial venous thrombosis, dissection of
cervical arteries (extra or intracranial, carotid or
vertebral), pituitary apoplexy, reversible cerebral
vasoconstriction syndrome, unruptured but
symptomatic aneurysm (eg, third cranial nerve
palsy).
Fewer sequences if cervical and
transcranial Doppler shows abnormalities
suggesting dissection or an increase in
intracranial flow velocities suggesting
reversible cerebral vasoconstriction
syndrome
Acute infarct less than 3 h not visualised on CT
scan, CSF hypotension, and better visualisation
of all abnormalities previously seen on CT.
Catheter angiography Gold standard for subarachnoid
haemorrhage. Particularly if increasing
headaches, and occurrence/increase of
focal deficits, unexplained after
CT scan, CSF analysis and complete
MRI/MRA/MRV
Ruptured aneurysm in 85% of patients with
subarachnoid haemorrhage, intracranial venous
thrombosis, dissection (cervical, intracranial),
reversible cerebral vasoconstriction syndrome,
differential diagnosis of cerebral arteritis,
unruptured but symptomatic aneurysm (third
nerve palsy)
ESR, erythrocyte sedimentation rate; MRA, MR angiography; MRV, MR venography.
265Ducros, Bousser
www.practical-neurology.com
effort for 1 or 2 weeks. Finally, it is important
to search for all possible vasoactive sub-
stances (repeated questioning is sometimes
necessary), stop them and firmly suggest to
the patient that he or she avoid these kinds of
drugs and medications in the future.
In the absence of any randomised trial,
empirical treatment is based on nimodipine,
started when the typical angiographic pattern
is demonstrated.
2, 14, 38, 39
This may be given
intravenously for a few days, in the same
doses as for aneurysmal SAH (1–2 mg/kg/h
with monitoring of blood pressure). More
often, nimodipine is given orally, the dose
varying from 60 mg every 4–8 h, for 4–
12 weeks. The effect this has on the various
symptoms and complications is unclear.
Thunderclap headaches seem to stop within
48–72 h but transient ischaemic attacks or
even infarction have been reported in patients
treated for several days.
3, 38
Moreover, in our
experience, some patients have an increase in
their background headaches on nimodipine,
and rarely a thunderclap headache triggered
by a nimodipine tablet. Finally, nimodipine
should be avoided in patients with low blood
pressure and in patients with an associated
dissection with haemodynamic compromise.
Steroids are not recommended. In a severe
case without improvement on nimodipine,
Canadian authors have tried intra-arterial
milrinone with a good outcome.
40
ACKNOWLEDGEMENTS
This article was reviewed by Keith Muir,
Glasgow, UK.
Competing interests: None.
REFERENCES
1. The International Classification of Headache
Disorders. Cephalalgia 2004;24:1–160.
2. Calabrese LH, Dodick DW, Schwedt TJ, et al.
Narrative review: reversible cerebral
vasoconstriction syndromes. Ann Intern Med
2007;146:34–44.
3. Ducros A, Boukobza M, Porcher R, et al. The clinical
and radiological spectrum of reversible cerebral
vasoconstriction syndrome. A prospective series of
67 patients. Brain 2007;130:3091–101.
4. Edlow BL, Kasner SE, Hurst RW, et al. Reversible
cerebral vasoconstriction syndrome associated with
subarachnoid hemorrhage. Neurocrit Care
2007;7:203–10.
5. Moskowitz SI, Calabrese LH, Weil RJ. Benign
angiopathy of the central nervous system
presenting with intracerebral hemorrhage. Surg
Neurol 2007;67:522–7.
6. Chen SP, Fuh JL, Chang FC, et al.Transcranialcolor
doppler study for reversible cerebral vasoconstriction
syndromes. Ann Neurol 2008;63:751–7.
7. Singhal AB, Caviness VS, Begleiter AF, et al. Cerebral
vasoconstriction and stroke after use of
serotonergic drugs. Neurology 2002;58:130–3.
8. Singhal AB. Cerebral vasoconstriction syndromes.
Top Stroke Rehabil 2004;11:1–6.
9. Williams TL, Lukovits TG, Harris BT, et al. A fatal
case of postpartum cerebral angiopathy with
literature review. Arch Gynecol Obstet
2007;275:67–77.
10. Dodick DW, Brown RD, Britton JW, et al.
Nonaneurysmal thunderclap headache with diffuse,
multifocal, segmental, and reversible vasospasm.
Cephalalgia 1999;19:118–23.
11. Call GK, Fleming MC, Sealfon S, et al. Reversible
cerebral segmental vasoconstriction. Stroke
1988;19:1159–70.
12. Calabrese LH, Gragg LA, Furlan AJ. Benign
angiopathy: a distinct subset of angiographically
defined primary angiitis of the central nervous
system. J Rheumatol 1993;20:2046–50.
13. Hajj-Ali RA, Furlan A, Abou-Chebel A, et al. Benign
angiopathy of the central nervous system: cohort
of 16 patients with clinical course and long-term
followup. Arthritis Rheum 2002;47:662–9.
14. Chen SP, Fuh JL, Lirng JF, et al. Recurrent primary
thunderclap headache and benign CNS angiopathy:
spectra of the same disorder? Neurology
2006;67:2164–9.
15. Kirton A, Diggle J, Hu W, et al. A pediatric case of
reversible segmental cerebral vasoconstriction.
Can J Neurol Sci 2006;33:250–3.
PRACTICE POINTS
lThe reversible cerebral vasoconstriction syndrome is more frequent than
previously thought and affects patients of both genders, with a female
preponderance.
lIt is attributed to a transient disturbance in the control of cerebral vascular
tone leading to multifocal arterial constrictions and dilatations.
lSome cases are spontaneous while others (60%) are secondary, mostly to
exposure to vasoactive substances and to the postpartum state.
lThe syndrome has a characteristic course; the onset is sudden followed by
a monophasic course, generally without new events after 1 month. The
main pattern is of recurrent thunderclap headaches.
lCortical subarachnoid haemorrhage, intracerebral haemorrhage, seizures
and the reversible posterior encephalopathy syndrome are early
complications, occurring mainly within the first week.
lIschaemic events, including transient ischaemic attacks and cerebral
infarction, occur later than any haemorrhagic strokes, mainly during the
second week.
lDiagnosis requires the demonstration of the characteristic ‘‘string of
beads’’ on cerebral angiography, the definitive diagnosis being made when
a later angiogram shows resolution or at least marked improvement of the
arterial abnormalities after about 12 weeks.
lNimodipine is the proposed treatment but in our experience does not seem
very effective; randomised trials are needed.
lRelapses do occur but are rare
266 Practical Neurology
10.1136/jnnp.2009.187856
16. Singhal AB. Postpartum angiopathy with reversible
posterior leukoencephalopathy. Arch Neurol
2004;61:411–16.
17. Noskin O, Jafarimojarrad E, Libman RB, et al.
Diffuse cerebral vasoconstriction (Call–Fleming
syndrome) and stroke associated with
antidepressants. Neurology 2006;67:159–60.
18. Schievink WI, Maya MM, Chow W, et al. Reversible
cerebral vasoconstriction in spontaneous intracranial
hypotension. Headache 2007;47:284–7.
19. Arnold M, Camus-Jacqmin M, Stapf C, et al.
Postpartum cervicocephalic artery dissection.
Stroke 2008;39:2377–9.
20. Hinchey J, Chaves C, Appignani B, et al. A reversible
posterior leukoencephalopathy syndrome.
N Engl J Med 1996;334:494–500.
21. Bartynski WS. Posterior reversible encephalopathy
syndrome, part 1: fundamental imaging and clinical
features. AJNR Am J Neuroradiol 2008;29:1036–42.
22. Lee VH, Wijdicks EF, Manno EM, et al. Clinical
spectrum of reversible posterior
leukoencephalopathy syndrome. Arch Neurol
2008;65:205–10.
23. Bartynski WS, Boardman JF. Catheter angiography,
MR angiography, and MR perfusion in posterior
reversible encephalopathy syndrome. AJNR
Am J Neuroradiol 2008;29:447–55.
24. Chen SP, Fuh JL, Lirng JF, et al. Is vasospasm
requisite for posterior leukoencephalopathy in
patients with primary thunderclap headaches?
Cephalalgia 2006;26:530–6.
25. Bartynski WS. Posterior reversible encephalopathy
syndrome, part 2: controversies surrounding
pathophysiology of vasogenic edema. AJNR
Am J Neuroradiol 2008;29:1043–9.
26. Dodick DW, Eross EJ, Drazkowski JF, et al.
Thunderclap headache associated with reversible
vasospasm and posterior leukoencephalopathy
syndrome. Cephalalgia 2003;23:994–7.
27. Ursell MR, Marras CL, Farb R, et al. Recurrent
intracranial hemorrhage due to postpartum
cerebral angiopathy: implications for management.
Stroke 1998;29:1995–8.
28. Spitzer C, Mull M, Rohde V, et al. Non-traumatic
cortical subarachnoid haemorrhage: diagnostic
work-up and aetiological background.
Neuroradiology 2005;47:525–31.
29. Moustafa RR, Allen CM, Baron JC. Call-Fleming
syndrome associated with subarachnoid
haemorrhage: three new cases. J Neurol Neurosurg
Psychiatry 2008;79:602–5.
30. Santos E, Zhang Y, Wilkins A, et al. Reversible
cerebral vasoconstriction syndrome presenting
with haemorrhage. J Neurol Sci 2009;276:189–92.
31. Slivka A, Philbrook B. Clinical and angiographic
features of thunderclap headache. Headache
1995;35:1–6.
32. Schwedt TJ, Matharu MS, Dodick DW. Thunderclap
headache. Lancet Neurol 2006;5:621–31.
33. Ducros A. Thunderclap headache. Rev Neurol (Paris)
2005;161:713–15.
34. Calabrese LH, Furlan AJ, Gragg LA, et al. Primary
angiitis of the central nervous system: diagnostic
criteria and clinical approach. Cleve Clin J Med
1992;59:293–306.
35. Koopman K, Uyttenboogaart M, Luijckx GJ, et al.
Pitfalls in the diagnosis of reversible cerebral
vasoconstriction syndrome and primary angiitis of
the central nervous system. Eur J Neurol
2007;14:1085–7.
36. Serdaru M, Chiras J, Cujas M, et al. Isolated benign
cerebral vasculitis or migrainous vasospasm?
J Neurol Neurosurg Psychiatry 1984;47:73–6.
37. Martin K, Rogers T, Kavanaugh A. Central nervous
system angiopathy associated with cocaine abuse.
J Rheumatol 1995;22:780–2.
38. Lu SR, Liao YC, Fuh JL, et al. Nimodipine for
treatment of primary thunderclap headache.
Neurology 2004;62:1414–16.
39. Zuber M, Touze E, Domigo V, et al. Reversible
cerebral angiopathy: efficacy of nimodipine.
J Neurol 2006;253:1585–8.
40. Bouchard M, Verreault S, Gariepy JL, et al. Intra-
arterial milrinone for reversible cerebral
vasoconstriction syndrome. Headache 2008;21:21.
267Ducros, Bousser
www.practical-neurology.com
... The etiology of RCVS was undetermined in all cases, as none of the patients had a history of precipitating factors [7,8]. Interestingly, while RCVS is typically more common in females, our cohort showed an equal distribution of male and female patients. ...
... In one patient, the initial diagnostic CT imaging, including the MR angiogram, appeared normal. This finding, suggested by Ducros and Bousser [7] may be attributed to vasoconstriction in RCVS occurring initially in the small peripheral vessels before extending to major vessels, thereby remaining undetectable on early imaging. ...
... According to existing literature, RCVS patients typically present with acute severe headaches, normal MRI brain imaging, or focal SAH, intracerebral hemorrhage, watershed territory infarcts, cerebral edema, and normal CSF analysis [7,8]. In contrast, PACNS patients present with a gradual onset of symptoms that progress over time. ...
Article
Full-text available
Introduction Reversible cerebral vasoconstriction syndrome (RCVS) is most commonly characterized by focal or diffuse severe thunderclap headache with or without focal neurological deficits and associated transient focal vasoconstriction of the intracerebral arteries lasting up to three months. We present six patients diagnosed as RCVS, with three patients presenting with focal neurological deficits without headache and the remaining three with severe headache alone. Neuroimaging revealed focal subarachnoid bleed with or without segmental intracerebral vasospasm, which resolved over three months. Despite thunderclap headache being the most prevalent symptom associated with RCVS, the absence of this symptom should not preclude the diagnosis, especially in the presence of cortical subarachnoid hemorrhage (SAH) or focal segmental intracerebral arterial narrowing. Methods This case series is a retrospective analysis of all patients diagnosed with RCVS between 2018 and 2022, focusing on clinical symptoms, imaging findings, and management. Results Six patients (three males and three females) were diagnosed with RCVS between 2018 and 2022. Three patients presented with typical symptoms, while the remaining three presented with atypical symptoms. Neuroimaging findings ranged from normal to focal SAH with or without arterial narrowing. Conclusion This case series underscores the diverse clinical presentations of RCVS, emphasizing that while thunderclap headache is the predominant symptom, its absence should not exclude the possibility of RCVS, especially when accompanied by focal neurological deficits or cortical SAH. Neuroimaging played a crucial role in identifying the spectrum of findings. These findings highlight the importance of comprehensive evaluation and consideration of RCVS in patients presenting with neurological symptoms, even in the absence of typical headache features.
... The confirmation of PA in pregnant females required an emergency cesarean section due to visual field progressive anomalies [82]. However, since PA is typically diagnosed in advanced pregnancies, data on healthy living are specifically provided in 29 reports [20,[69][70][71]73,74,76,77,79,[81][82][83][84][85][86][87][88][89][90][92][93][94][95][96][97][98]. ...
... The low number of cases found between 2012 and 2022, however, suggests the rarity of the disease. The clinical presentation of patients with PA in pregnancy and PP is similar to the clinical presentation of non-pregnant patients with PA with sudden and severe headache; nausea and vomiting; visual disturbances including a decrease in visual acuity; and signs and symptoms of cranial nerve palsies such as visual field defects, ptosis, anisocoria, and diplopia [14,39,[98][99][100][101][102]. Presentation with hypocortisolism occurred in one of the patients with PA in pregnancy [91]. ...
... Its frequency is higher during PP. Its resolution is spontaneous, but it may lead to subarachnoid hemorrhage and even hemorrhagic or ischemic strokes [98,[106][107][108]. ...
Article
Full-text available
Our purpose is to provide new insights concerning the challenges of pituitary apoplexy in pregnancy (PAP) and the postpartum period (PAPP). This is a narrative review of the English literature using a PubMed search. The inclusion criteria were clinically relevant original studies (January 2012–December 2022). Overall, we included 35 original studies: 7 observational studies (selected cases on PA) and 28 case reports, including 4 case series (N = 49; PAP/PAPP = 43/6). The characteristics of PAP patients (N = 43) are as follows: maternal age between 21 and 41 (mean of 27.76) years; 21/43 subjects with a presentation during the third trimester (only one case during first trimester); average weak of gestation of 26.38; most females were prim gravidae; 19 (out of 30 patients with available data on delivery) underwent a cesarean section. Headache remains the main clinical feature and is potentially associated with a heterogeneous panel (including visual anomalies, nausea, vomiting, cranial nerve palsies, diabetes insipidus, photophobia, and neck stiffness). Pre-pregnancy medication included dopamine agonists (15/43) and terguride (1/43) in addition to subsequent insulin therapy for gestational diabetes (N = 2) and type 1 diabetes mellitus (N = 1). Overall, 29/43 females received the conservative approach, and 22/43 women had trans-sphenoidal surgery (TSS) (and 10/22 had the initial approach). Furthermore, 18/43 patients had a pituitary adenoma undiagnosed before pregnancy. Most PA-associated tumors were prolactinomas (N = 26/43), with the majority of them (N = 16/26) being larger than 1 cm. A maternal–fetal deadly outcome is reported in a single case. The characteristics of PAPP patients (N = 6) are as follows: mean age at diagnosis of 33 years; 3/6 subjects had PA during their second pregnancy; the timing of PA varied between 5 min and 12 days after delivery; headache was the main clinical element; 5/6 had no underlying pituitary adenoma; 5/6 patients were managed conservatively and 1/6 underwent TSS; pituitary function recovered (N = 3) or led to persistent hypopituitarism (N = 3). In conclusion, PAP represents a rare, life-threatening condition. Headache is the most frequent presentation, and its prompt distinction from other conditions associated with headache, such as preeclampsia and meningitis, is essential. The index of suspicion should be high, especially in patients with additional risk factors such as pre-gestation treatment with dopamine agonists, diabetes mellitus, anticoagulation therapy, or large pituitary tumors. The management is conservative in most cases, and it mainly includes corticosteroid substitution and dopamine agonists. The most frequent surgical indication is neuro-ophthalmological deterioration, although the actual risk of pituitary surgery during pregnancy remains unknown. PAPP is exceptionally reported. To our knowledge, this sample–case series study is the largest of its kind that is meant to increase the awareness to the benefit of the maternal–fetal outcomes from multidisciplinary insights.
... It is characterized by the sudden onset (reaching peak intensity within <1 min) of an acute, severe and explosive headache of the thunderclap type [26] and reversible cerebral vasoconstriction. The headache often has a posterior onset and can be accompanied by nausea, vomiting, a confusional state, photophobia, phonophobia and visual changes [27]. Generalized tonic-clonic seizures and focal deficits have been reported as well [28]. ...
... Generalized tonic-clonic seizures and focal deficits have been reported as well [28]. The daily recurrence of episodes of sudden-onset, high-intensity headache with a duration of several weeks after the first episode is almost pathognomonic [27]. ...
Article
Full-text available
Neurological complications in pregnancy and the puerperium deserve particular attention from specialists due to the worsening of the clinical picture for both the mother and the fetus. This narrative review of existing data in the literature aims to analyze the most common “red flag symptoms” attributable to neurological complications such as pre-eclampsia (PE), eclampsia, HELLP syndrome, posterior reversible encephalopathy syndrome (PRES), cerebral vasoconstriction syndrome (RCVS), stroke, CVS thrombosis, pituitary apoplexy, amniotic fluid embolism and cerebral aneurysm rupture, with the aim of providing a rapid diagnostic algorithm useful for the early diagnosis and treatment of these complications. The data were derived through the use of PubMed. The results and conclusions of our review are that neurological complications of a vascular nature in pregnancy and the puerperium are conditions that are often difficult to diagnose and manage clinically. For the obstetrics specialist who is faced with these situations, it is always important to have a guide in mind in order to be able to unravel the difficulties of clinical reasoning and promptly arrive at a diagnostic hypothesis.
... The diagnosis of RCVS requires a high clinical suspicion with recognition of the typical signs and symptoms of the condition, commonly recognized precipitating agents, and common radiographic features. Management of RCVS involves avoidance of the precise precipitating agent once identified [7]. In our report, we present two atypical cases of recurrent RCVS associated with recurrent exposures to precipitating agents and profound neurological complications. ...
Article
Full-text available
Reversible cerebral vasoconstriction syndrome (RCVS) is a rare neurological condition that classically presents with recurrent, thunderclap headaches and radiographic findings of multifocal narrowing of cerebral vasculature. Complications of RCVS may include ischemic or hemorrhagic strokes. Sympathomimetic agents including cannabinoids have been associated as precipitants in many cases. RCVS is classically considered to be reversible, although cases of recurrent RCVS have been described in the literature. In this report, we describe two cases of recurrent RCVS, which were precipitated by recurrent exposures to inciting agents. The first patient was found to have a history of repeated exposure to tetrahydrocannabinol (THC) and suffered from recurrent multifocal ischemic strokes with evidence of persistent multifocal narrowing of cerebral vasculature by cerebral arteriography. The second case describes a patient with a history of use of ashwagandha, medical marijuana, and serotonin-norepinephrine reuptake inhibitors (SNRIs) who experienced multiple intracranial hemorrhages with radiographic evidence of multifocal narrowing of cerebral vessels as well.
... También puede presentarse de forma espontánea, algunas series muestran que los desencadenantes no se encuentran entre un 25 % a un 60 % de los casos y su relación tiempo exposición puede ir desde días hasta meses 9 . La asociación con el posparto está estudiada en amplitud, por lo general se presenta en partos no complicados en las primeras tres semanas o hasta seis semanas posparto, explicado por factores pro y antiangiogénicos del embarazo, al igual que por los factores de crecimiento placentarios 10 . ...
Article
Full-text available
El síndrome de vasoconstricción cerebral reversible es poco frecuente y su fisiopatología aún no está bien dilucidada. Su presentación clínica se caracteriza por manifestaciones neurológicas como cefalea “en trueno”, déficit focal, vómito, fotofobia y, en casos graves, puede tener complicaciones como eventos cerebrovasculares isquémicos o hemorrágicos. El diagnóstico se realiza mediante angiografía cerebral, angiotomografía o angioresonancia, las cuales documentan vasoconstricción de las arterias cerebrales con resolución espontánea, que en la mayoría de los casos es consistente con un buen pronóstico clínico. A continuación, se expone el caso de una paciente con vasoconstricción cerebral reversible y lesión miocárdica asociada, en donde se logra un diagnóstico mediante imágenes y tratamiento oportuno. La importancia del caso radica en informar sobre el reconocimiento temprano de una complicación miocárdica poco común del síndrome de vasoconstricción cerebral, pero con riesgo de morbimortalidad dentro del espectro de los cuadros cerebrovasculares.
... In severe preeclampsia and eclampsia neurological complications may arise from co-existence of reversible cerebral vasoconstriction syndrome and posterior leucoencephalopathy syndrome, giving rise to clinical features like headache, reversible blindness, confusion, and convulsions (18)(19)(20)(21). Reversible cerebral vasoconstriction syndrome is associated with subarachnoid and intracerebral haemorrhage and posterior leukoencephalopathy syndrome results in diffuse vasogenic oedema (22,23). ...
Article
Full-text available
PubMed ID : 36919381 PubMed Central : PMC10019004 Objective: To estimate the incidence of raised intracranial pressure (ICP) as evident by enlarged optic nerve sheath diameter (ONSD) by ocular ultrasound among patients with preeclampsia and its relationship to severity of disease. Material and Methods: Sixty pregnant mothers with preeclampsia were compared to 30 normotensive, uncomplicated pregnant controls. For ONSD measurement, a 7-MHZ linear probe was used and three values from each optic nerve were taken and the mean of six values of both eyes was recorded. All study subjects were followed until seven days after delivery. Results: Two cut off values (5.8 mm and 4.6 mm) were used to compare ONSD in severe and non-severe preeclampsia with that of healthy pregnant individuals. The incidence of raised ICP among severe preeclampsia above 5.8 mm and 4.6 mm cut-off were 43.3% and 90%, respectively, before delivery. ONSD was significantly elevated among preeclampsia subjects at both cut-off values at pre-delivery (p=0.004 for ONSD >5.8 mm and p<0.001 for ONSD >4.6 mm) compared to controls. There a significant association between presence of neurological manifestations and enlarged ONSD (p<0.001 for ONSD >5.8 mm and p=0.04 for ONSD >4.6 mm) before delivery. Conclusion: Severe preeclampsia with neurological features was associated with increased ONSD, reflecting raised ICP. Further studies are needed to compare ONSD values with invasive ICP monitoring for better understanding of this relationship. Keywords: Preeclampsia, optic nerve sheath diameter, intracranial pressure, ultrasonography
Chapter
Reversible cerebral vasoconstriction syndrome (RCVS) is a transient disturbance in cerebral vascular tone with subsequent multifocal segmental intracerebral arterial constriction and dilation. It typically presents with recurrent thunderclap headaches, and with focal neurological deficits if cerebral infarction has occurred. Cerebral angiography demonstrates multifocal segmental narrowing and dilatation which normalises within three months. Differentiation from primary CNS angiitis can be made clinically, and from aneurysmal subarachnoid haemorrhage radiologically. Management includes enquiring about and discontinuing any potential precipitants and commencement of calcium channel blockers may be beneficial. Prognosis is favourable, but dependent on the extent of cerebral infarction.
Article
Headache is worldwide one of the leading reasons to consult a general practitioner or a neurologist. In addition to the medical history and results of laboratory parameters, imaging represents one of the most important diagnostic steps. As there is a myriad of possible causes, it is nearly impossible to cover the whole spectrum of this topic. This article summarizes the most important morphological imaging findings and their pitfalls.
Chapter
Reversible vasoconstriction syndrome (RCVS) is a poorly understood disease heralded by multiple areas of vasoconstriction on cerebral vessel imaging that later resolve. It more commonly affects females than males and although its pathophysiology is not clearly understood, it appears to be multi-factorial and may share many features with posterior reversible encephalopathy and eclampsia. In the pregnant patient it appears most commonly in the post-partum period and is commonly associated with cerebrovascular events such as intracerebral hemorrhage, stroke, and cerebral venous thrombosis. Clinically, the patient with RCVS will present with recurrent thunderclap headaches and will typically require assessment for aneurysmal subarachnoid hemorrhage. Clinical suspicion must be high as vascular imaging may not demonstrate vasoconstrictive lesions for several days to weeks requiring repeat imaging. Treatment typically consists of vasodilators and analgesia with most patients reporting a good outcome.
Article
TACROLIMUS, a mainstay of immunosuppression after orthotopic heart transplantation (OHT), is associated with a broad range of side effects. Vasoconstriction caused by tacrolimus has been proposed as a mechanism underlying common side effects such as hypertension and renal injury. Neurologic side effects attributed to tacrolimus include headaches, posterior reversible encephalopathy syndrome (PRES), or reversible cerebral vasospasm syndrome (RCVS). Six case reports have been published describing RCVS in the setting of tacrolimus administration after OHT. The authors report a case of perfusion-dependent focal neurologic deficits attributed to tacrolimus-induced RCVS in an OHT recipient.
Article
Full-text available
Article
Full-text available
The Call-Fleming syndrome (CFS) comprises acute severe recurrent (thunderclap) headaches, occasional transient or fluctuating neurological abnormalities and reversible segmental cerebral vasoconstriction. It is a benign condition with an excellent prognosis, yet because it is often clinically and radiologically similar to a number of commonly encountered conditions, diagnostic difficulties may arise, leading to inappropriate, and even potentially harmful, investigative and therapeutic approaches. Three personal cases are presented to highlight the occurrence of subarachnoid haemorrhage (SAH) as part of CFS. In two patients with a positive CT head, SAH involved the sulci in the upper cerebral convexity, an unusual location in aneurysmal SAH. SAH is not an uncommon feature of CFS, occurring in approximately 25% of reported cases, and may pose a diagnostic challenge. CFS has a relatively characteristic spectrum of features, allowing a confident diagnosis in most cases, even when atypical features such as SAH are present. Recognising the spectrum of abnormalities seen in CFS, including particularly SAH, allows a sound approach to a safe diagnosis.
Article
Full-text available
Vasoconstriction is not recognized as a cause of cerebrovascular disease except in the vasospasm seen following subarachnoid hemorrhage and possibly in migraine. However, we found four patients to have transient, fully reversible vasoconstriction and dilatation prominently involving arteries around the circle of Willis. All four patients were evaluated for severe headaches and fluctuating or recurring motor or sensory deficits. No cause for the clinical syndromes and angiographic abnormalities was found. Similar patients are reported in the literature under various nosologies. This newly recognized clinical-angiographic syndrome should be differentiated from other known causes of vessel constriction and dilatation; the precipitants of reversible vasoconstriction may then be better defined.
Article
Reversible cerebral vasoconstriction syndromes (RCVS) comprise a group of diverse conditions, all characterized by reversible multifocal narrowing of the cerebral arteries heralded by sudden (thunderclap), severe headaches with or without associated neurologic deficits. Reversible cerebral vasoconstriction syndromes are clinically important because they affect young persons and can be complicated by ischemic or hemorrhagic strokes. The differential diagnosis of RCVS includes conditions associated with thunder-clap headache and conditions that cause irreversible or progressive cerebral artery narrowing, such as intracranial atherosclerosis and cerebral vasculitis. Misdiagnosis as primary cerebral vasculitis and aneurysmal subarachnoid hemorrhage is common because of overlapping clinical and angiographic features. However, unlike these more ominous conditions, RCVS is usually self-limited: Resolution of headaches and vasoconstriction occurs over a period of days to weeks. In this review, we describe our current understanding of RCVS; summarize its key clinical, laboratory, and imaging features; and discuss strategies for diagnostic evaluation and treatment.
Article
Cephalalgia has been successful by a number of measures in the last 12 months: our circulation is up particularly through electronic penetration in libraries, our submission rate has risen substantially and our impact factor remains high amongst clinical neuroscience journals. We are entering our fifth and last year of the current publisher’s contract. In the life of the contract we have switched to a very successful on-line submission system, finalized details for a new CDROM containing all issues of Cephalalgia and Headache, and will publish this year the revised International Headache Society classification for headache (1). All of this is excellent progress The journal continues to attract a range of important, interesting and often very thought-provoking submissions. We have benefitted greatly from the broad range of interests of the Associate Editors we are able to recommend and solicit high-quality expert reviews that keep the scientific standards high. In keeping with our general philosophy there is a need for renewal amongst the Associate Editors, and Professor Peer Tfelt-Hansen will be standing down. Peer is widely regarded as one of the most authoritative figures on clinical trial methodology in headache, his wide contributions to the field have appropriately lead to his election as President of the International Headache Society. The journal thanks him for his contributions, and congratulates him on his election. After wide consultation I have invited Professor Nahib Ramadan, University of Chicago, to join the Associate Editors. Professor Ramadan was extensively involved in the journal under the previous Editor-in-Chief, Professor K. Michael Welch, and brings both excellence in academic life and a stint in industry with that important perspective to the Board. I welcome his acceptance of the invitation. From this issue Cephalalgia will become a monthly journal. We have a strong throughput of excellent work and rather than raise the rejection rate, and somewhat arbitrarily dismiss work that readers might be very interested in seeing, we felt it timely to increase to 12 issues a year. We hope this will allow more rapid publication of your accepted work and a greater range of interesting papers for readers in any one year. Let me close by thanking the Editorial Assistant Faye Cheeseman for her sterling efforts at the Blackwell’s Office in keeping the journal ticking over, our referees whose expertise is the key to our success, the Associate Editors who do so much for the journal, and you the reader for your continued support for Cephalalgia.
Article
Objective Reversible cerebral vasoconstriction syndromes (RCVS) are characterized by thunderclap headaches and reversible cerebral vasoconstrictions. No systematic studies on cerebral hemodynamics have been published.Methods Patients with RCVS were consecutively recruited. Sequential transcranial color-coded sonography studies were performed on the middle cerebral artery (MCA) for 3 months. Mean flow velocities (VMCA) and Lindegaard Index (LI) were recorded and compared with those of controls.ResultsThirty-two patients (all female; average age, 49.7 ± 6.8 years) were enrolled. Four developed of reversible posterior leukoencephalopathy syndrome, and two of them, ischemic strokes. One hundred and twenty-six sonography studies were performed on 57 eligible MCAs. The mean maximum VMCA (109.5 ± 30.8cm/sec) and LI (2.2 ± 0.7) of RCVS patients exceeded those of controls (VMCA: 66.3 ± 9.5cm/sec, p < 0.001; LI: 1.4 ± 0.3, p < 0.001). The VMCA and LI levels were still at their plateau at the mean time (day 22 after headache onset) of headache resolution. Fifteen (46.9%) patients had VMCA exceeding 120cm/sec, and 5 (16%) had LI exceeding 3. Patients fulfilling the criteria of subarachnoid hemorrhage mild vasospasm (n = 4; 13%), that is, both VMCA greater than 120cm/sec and LI greater than 3, had a greater risk of posterior leukoencephalopathy (75 vs 4%; p = 0.003) and ischemic strokes (50 vs 0%; p = 0.01) than those without.InterpretationPatients with RCVS experienced prolonged vasoconstriction, making the risk for posterior leukoencephalopathy and ischemic strokes outlast headache resolution. Patients fulfilling mild vasospasm criteria for subarachnoid hemorrhage carry a high risk. Ann Neurol 2008
Article
Reversible cerebral vasoconstriction syndrome (RCVS) usually presents with recurrent thunderclap headaches and is characterized by multifocal and reversible vasoconstriction of cerebral arteries that can sometimes evolve to severe cerebral ischemia and stroke. We describe the case of a patient who presented with a clinically typical RCVS and developed focal neurological symptoms and signs despite oral treatment with calcium channel blockers. Within hours of neurological deterioration, she was treated with intra-arterial milrinone, a phosphodiesterase inhibitor, which resulted in a rapid and sustained neurological improvement.
Article
Reversible cerebral vasoconstriction syndromes are characterized by prolonged but reversible vasoconstriction of the cerebral arteries, presenting typically with thunderclap headache, with or without focal neurological signs or symptoms. They resemble primary central nervous system vasculitis but it is critical to differentiate these two entities. Here we draw attention to intracranial haemorrhage as an important and not uncommon clinical feature in reversible cerebral vasoconstriction syndrome. Four patients with reversible cerebral vasoconstriction syndrome, each presenting to a single unit with intracranial haemorrhage, are described. These descriptions of haemorrhage at presentation of RCVS extend the recognised clinical phenotype and so help to enhance recognition and diagnosis of this often unconsidered disorder.
Article
Primary angiitis of the central nervous system has until recently been considered rare, usually progressive, and untreatable. In 1987, preliminary diagnostic criteria for the disorder were proposed in the hope of gaining a more accurate description of the disease. We used these criteria in reviewing all cases reported in the English language (99 cases) and those seen at The Cleveland Clinic Foundation (9 cases). We believe that the disorder is heterogeneous, and has a better prognosis than previously thought. Furthermore, a relatively benign subset of this disorder, termed "benign angiopathy of the central nervous system," can be defined on clinical grounds. We propose a revised set of diagnostic criteria and a practical approach to treatment.
Article
A 39-year-old woman experienced severe headache, epilepsy and rapidly progressive aphasia and hemianopia. Carotid angiograms displayed segmentary narrowing of intracranial arteries as previously described in benign cerebral vasculitis. Her superficial temporal artery was also involved, allowing a biopsy of the abnormal part of the vessel. Microscopical study of this artery was normal. A second carotid angiogram, 14 days later, showed normal intracranial arteries. These findings suggest arterial spasm rather than distal arteritis.